JPH043918B2 - - Google Patents
Info
- Publication number
- JPH043918B2 JPH043918B2 JP60145698A JP14569885A JPH043918B2 JP H043918 B2 JPH043918 B2 JP H043918B2 JP 60145698 A JP60145698 A JP 60145698A JP 14569885 A JP14569885 A JP 14569885A JP H043918 B2 JPH043918 B2 JP H043918B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- printing
- yellow blood
- water
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 16
- 235000012247 sodium ferrocyanide Nutrition 0.000 claims description 16
- 235000002949 phytic acid Nutrition 0.000 claims description 15
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 8
- 229940068041 phytic acid Drugs 0.000 claims description 8
- 239000000467 phytic acid Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- 239000000976 ink Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- -1 NH 4 Inorganic materials 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000005530 etching Methods 0.000 description 6
- 239000000080 wetting agent Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 235000011007 phosphoric acid Nutrition 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229940083982 sodium phytate Drugs 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
- B41N—PRINTING PLATES OR FOILS; MATERIALS FOR SURFACES USED IN PRINTING MACHINES FOR PRINTING, INKING, DAMPING, OR THE LIKE; PREPARING SUCH SURFACES FOR USE AND CONSERVING THEM
- B41N3/00—Preparing for use and conserving printing surfaces
- B41N3/08—Damping; Neutralising or similar differentiation treatments for lithographic printing formes; Gumming or finishing solutions, fountain solutions, correction or deletion fluids, or on-press development
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は電子写真オフセツトマスター、銀塩印
刷版、PS版の印刷に用いる湿し水に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a dampening solution used for printing electrophotographic offset masters, silver salt printing plates, and PS plates.
[従来の技術]
電子写真オフセツトマスターはまず酸化亜鉛の
如き光導電性微粉末を電気絶縁性樹脂と共に支持
体上に塗布してなる感光層上に、電子写真的手法
により親油性画像を得る。次にエチツチング処理
により非画像部を親油性から親水性に転換して印
刷版とする。印刷版中も初期の親水性を維持する
ために通常エツチング液を数倍に希釈して湿し水
として用いる。[Prior Art] An electrophotographic offset master first obtains a lipophilic image by an electrophotographic method on a photosensitive layer formed by coating a photoconductive fine powder such as zinc oxide on a support together with an electrically insulating resin. . Next, an etching process converts the non-image area from lipophilic to hydrophilic to form a printing plate. In order to maintain the initial hydrophilicity in the printing plate, the etching solution is usually diluted several times and used as a dampening solution.
また親油性筆記具またはタイプによつて直接マ
スターに記入して印刷版とする方式および電子写
真法を用いる方式がある。この場合も同様の湿し
水を使用する。 There are also methods of writing directly on the master using a lipophilic writing instrument or type to create a printing plate, and methods of using electrophotography. In this case, use the same dampening water.
これまでにも多くの湿し水処方の提案があつ
た。それらを主成分で分類すると黄血塩系と非黄
血塩系に分けられる。黄血塩系は従来用いられて
きている。これは熱および光にたいして不安定で
あり自然経時によつてもエツチング力の低下、沈
澱発生、公害性などの欠点があるものの総合的に
みた印刷特性は安定しているものと言うことがで
きる。 Many dampening solution formulations have been proposed so far. If they are classified according to their main components, they can be divided into yellow blood salt type and non-yellow blood salt type. Yellow blood salt systems have traditionally been used. Although it is unstable to heat and light and has drawbacks such as a decrease in etching power, generation of precipitation, and pollution over natural aging, it can be said that the overall printing characteristics are stable.
[発明が解決しようとする問題点]
しかしながら、黄血塩系ではどうしても印刷で
きない場合がある。すなわち従来、PS版に用い
られている速乾性の色インキで印刷した場合には
印刷物のよごれ、ローラーストリツプ、乳化等が
発生しやすく実用にならない。さらに最近徐々に
ではあるが印刷用紙に中性紙が使われることが多
くなつてきた。中性紙は従来の酸性紙と外観も感
触も極めて類似しているために容易に区別がつか
ない。そのために、知らずに印刷して汚れがどう
してもなおらず、困惑する場合がみうけられる。
エツチング回数を増やしたり湿し水のPHを低下さ
せたりしても、根本的な解決にはならない事は周
知の如くである。[Problems to be Solved by the Invention] However, there are cases where it is impossible to print with the yellow blood salt system. That is, when printing with quick-drying color inks conventionally used for PS plates, the printed matter tends to become smudged, roller striped, emulsified, etc., and is not practical. Furthermore, acid-free paper has been increasingly used for printing paper recently. Acid-free paper is very similar in appearance and feel to conventional acid-based paper and is therefore difficult to distinguish. For this reason, there are cases where printing without realizing it causes stains that cannot be removed, which can be confusing.
It is well known that increasing the number of times of etching or lowering the pH of the dampening water does not provide a fundamental solution.
一方、非黄血塩系の代表例としてはフイチン酸
塩系をあげることができる。しかしフイチン酸塩
のみでは親水化力が弱く、エツチング液として使
うには問題がある。だがこれを希釈して湿し水と
して使用した場合には、幾つかの問題点があるに
もかかわらずある程度印刷できることがある。そ
の問題点とは印刷状態が不安定で水およびインキ
の量を常に調節していないと汚れや水負け等が発
生しやすいこと、耐刷不良を起こしやすいこと、
ローラーストリツプになりやすいこと等である。 On the other hand, a typical example of a non-yellow blood salt type is a phytate type. However, phytate alone has a weak hydrophilicity and is problematic for use as an etching solution. However, if this is diluted and used as dampening water, printing may be possible to some extent despite some problems. The problems are that the printing condition is unstable, and if the amount of water and ink is not constantly adjusted, stains and water loss are likely to occur, and printing durability is likely to occur.
They tend to become roller strips, etc.
しかし本発明者等は詳細かつ厳密な研究および
論理的考察の結果、いずれの場合にも、上記トラ
ブルの原因はインキおよび中性紙に含まれる炭酸
カルシウムであることを見出すに到つた。即ち炭
酸カルシウムが印刷中に湿し水に溶け出し、カル
シウムイオンと湿し水成分の親水性反応物が生成
し、それが印刷機のローラー表面に堆積した場合
はローラーストリツプとなり、マスターのトナー
画像部に付着した場合は耐刷不良となる。更に溶
出した炭酸カルシウムは湿し水のPHを上昇させ、
親水化反応を阻害し汚れを発生させる。 However, as a result of detailed and rigorous research and logical considerations, the present inventors have discovered that in each case, the cause of the above-mentioned troubles is calcium carbonate contained in the ink and neutral paper. In other words, calcium carbonate dissolves into dampening water during printing, and a hydrophilic reaction product of calcium ions and dampening water components is produced. If this deposits on the roller surface of the printing press, it becomes a roller strip, and the master's If it adheres to the toner image area, printing durability will be poor. Furthermore, the eluted calcium carbonate increases the pH of the dampening solution,
It inhibits the hydrophilic reaction and causes stains.
[問題点を解決するための手段]
そこで本発明者等は炭酸カルシウムを溶出させ
ない方法、溶出しても湿し水成分と反応させない
方法、あるいは反応しても親水性反応物を生成し
ない方法、そしてPHを上昇させない方法等を探求
した結果、黄血塩とフイチン酸塩を特定の添加量
で併用した時に、いずれの場合にも安定して使用
し得る湿し水が得られることを発見するに到つ
た。それぞれの作用はいまだ完全に解明された訳
ではないのだが、主たる親水化反応は黄血塩が担
い少量のフイチン酸塩は緩やかな着肉不良反応を
おこして、マスター全面を汚れにくい状態にさせ
ているものと考えられる。そのために黄血塩系単
独の場合に生じる汚れがまつたく発生せず、また
フイチン酸塩系単独の場合に見られる障害がほと
んど発生しないものと思われる。[Means for Solving the Problems] Therefore, the present inventors proposed a method in which calcium carbonate is not eluted, a method in which calcium carbonate is not reacted with the dampening water component even if it is eluted, or a method in which a hydrophilic reactant is not generated even if it is reacted. As a result of searching for a method that would not increase the pH, they discovered that when yellow blood salt and phytate were used together in a specific amount, a dampening solution that could be stably used in any case was obtained. I reached it. Although the effects of each have not yet been fully elucidated, the main hydrophilic reaction is carried out by the yellow blood salt, and a small amount of phytate causes a mild inking reaction, making the entire surface of the master less likely to get dirty. It is thought that the For this reason, stains that occur when yellow blood salts are used alone do not occur, and it is thought that the problems that occur when phytate salts are used alone do not occur.
本発明においてはPH調節剤もしくはPH緩衝剤と
して後記する如き無機または有機の酸またはそれ
らの塩を加える事が出来るが、これらはまた前記
反応を効率良く促進すべく作用しているものと考
えられる。 In the present invention, inorganic or organic acids or their salts as described later can be added as PH regulators or PH buffers, but these are also considered to act to efficiently promote the reaction. .
黄血塩とフイチン酸塩を併用する提案は特公昭
45−24609号及び特開昭54−10003号に示されてい
るが、それらはエツチング液としての性能を改良
すべくなされたものであり、その本質はフイチン
酸塩は黄血塩に較べてエツチング力が劣るために
二者を併用してその欠点をカバーしたに過ぎない
と思われる。本発明の黄血塩の添加量範囲におい
ては酸性紙−墨インキと言つた通常の印刷条件で
は、何ら問題なく印刷できる(無論色インキおよ
び中性紙では地汚れを生じる)。しかしながらフ
イチン酸の添加量範囲ではこれを単独で用いた場
合には通常の印刷条件でも地汚れをも地汚れを生
じてしまうのである。その原因はこの添加量範囲
では親水化反応を起こし得ないからと推察され
る。そして黄血塩とフイチン酸を併用したときの
み、先に述べた如き機構によつて色インキあるい
は中性紙の印刷が可能になるのである。 The proposal to use yellow blood salt and phytate together was made by Tokkosho.
45-24609 and JP-A No. 54-10003, these were made to improve the performance as an etching solution. It seems that the two were used together to compensate for their inferiority due to their inferior strength. Within the range of the addition amount of yellow blood salt of the present invention, printing can be performed without any problem under normal printing conditions such as acidic paper and black ink (of course, background smear occurs with color ink and neutral paper). However, if phytic acid is used alone within the range of addition amount, background smear will occur even under normal printing conditions. The reason for this is presumed to be that the hydrophilization reaction cannot occur within this addition amount range. Only when yellow blood salt and phytic acid are used in combination, it becomes possible to print colored inks or neutral paper using the mechanism described above.
すなわち本発明は少なくとも黄血塩を1〜10
g/、フイチン酸またはその塩を0.1〜2g/
含有し、PHが3〜7である印刷用湿し水であ
る。 That is, the present invention uses at least 1 to 10 yellow blood salts.
g/, phytic acid or its salt 0.1 to 2 g/
It is a printing dampening water containing PH of 3 to 7.
本発明は更にPH調節剤、PH緩衝剤、湿潤剤、濡
れ剤、防錆剤、防錆剤等を添加することができ
る。 In the present invention, it is possible to further add a PH regulator, a PH buffer, a wetting agent, a wetting agent, a rust preventive, a rust preventive, and the like.
以下に本発明に使用し得る素材について説明す
る。 Materials that can be used in the present invention will be explained below.
黄血塩は一般式M4[Fe(CN)6]で表わされる
(ここでMはLi、Na、K、NH4、Rb、Csであ
る)。特にNa、Kの場合は性能的にもコスト的に
も極めて好ましい。 Yellow blood salt is represented by the general formula M 4 [Fe(CN) 6 ] (where M is Li, Na, K, NH 4 , Rb, Cs). In particular, Na and K are extremely preferable in terms of performance and cost.
フイチン酸塩はフイチン酸のアルカリ金属塩、
アンモニウム塩、およびアミン塩、等がある。 Phytate is an alkali metal salt of phytic acid,
There are ammonium salts, amine salts, etc.
PH調節剤、PH緩衝剤としては無機または有機の
酸またはその塩があり、単独もしくは混合して用
いる。例えば、無機酸としては、燐酸、硫酸、塩
酸、硝酸など、有機酸としてはギ酸、酢酸、酪
酸、吉草酸、乳酸、酒石酸、プロピオン酸があ
り、シユウ酸、マロン酸、コハク酸、グルタル
酸、マレイン酸、フタル酸、シトラコン酸、イタ
コン酸、フマル酸、トリカルバリル酸、グリコー
ル酸、プロピオン酸、チオグリコール酸、リンゴ
酸、クエン酸、グレコン酸、ピルピン酸、グルコ
ール酸、サルチル酸、アジピン酸、ヒドロアクリ
ル酸、グリセリン酸、p−トルエンスルホン酸、
ポリアクリル酸などがある。またそれらの塩とし
てはアルカリ金属塩、アンモニウム塩、アミン塩
等がある。酸解離定数が10-2〜10-13の酸又は塩
が好ましい。より好ましくは、有機酸またはその
塩を0.1〜50g/、特に0.5〜30g/含有す
る。また湿潤剤および濡れ剤としてエチレングリ
コール、ジエチレングリコール、トリエチレング
リコール、ポリエチレングリコール、グリセリ
ン、アラビアガム、カルボキシメチルセルロー
ス、アクリルポリマー、メタノール、エタノー
ル、イソおよびノルマルプロピルアルコール、ト
リエタノールアミンなどを加える事ができる。そ
して黄血塩の分解によるプルシアンブルーおよび
タンブルブルーなどの沈澱を防止するために
EDTA−2Naなどのキレート剤を加える事が望
ましい。 Inorganic or organic acids or salts thereof can be used as PH regulators and PH buffers, and they can be used alone or in combination. For example, inorganic acids include phosphoric acid, sulfuric acid, hydrochloric acid, and nitric acid; organic acids include formic acid, acetic acid, butyric acid, valeric acid, lactic acid, tartaric acid, and propionic acid; oxalic acid, malonic acid, succinic acid, glutaric acid, Maleic acid, phthalic acid, citraconic acid, itaconic acid, fumaric acid, tricarballylic acid, glycolic acid, propionic acid, thioglycolic acid, malic acid, citric acid, gleconic acid, pyrupic acid, glucolic acid, salicylic acid, adipic acid, Hydroacrylic acid, glyceric acid, p-toluenesulfonic acid,
Examples include polyacrylic acid. Examples of the salts include alkali metal salts, ammonium salts, and amine salts. Acids or salts having an acid dissociation constant of 10 -2 to 10 -13 are preferred. More preferably, the organic acid or its salt is contained in an amount of 0.1 to 50 g/, especially 0.5 to 30 g/. Furthermore, ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, glycerin, gum arabic, carboxymethyl cellulose, acrylic polymer, methanol, ethanol, iso and normal propyl alcohol, triethanolamine, etc. can be added as wetting agents and wetting agents. and to prevent precipitation of Prussian blue and tumble blue due to the decomposition of yellow blood salts.
It is desirable to add a chelating agent such as EDTA-2Na.
本発明では、黄血塩による不感脂化作用を十分
に発揮させるために、リン酸塩を加えることが好
ましく、リン酸塩は正リン酸、第1リン酸、第2
リン酸のアルカリ金属塩およびアンモニウム塩等
である。 In the present invention, in order to fully exhibit the desensitizing effect of the yellow blood salt, it is preferable to add a phosphate, and the phosphates include orthophosphoric acid, primary phosphoric acid, and secondary phosphoric acid.
These include alkali metal salts and ammonium salts of phosphoric acid.
更に防腐剤としてサリチル酸、フエノール、フ
エノールパラ安息香酸ブチル、デヒドロ酢酸ナト
リウム、4−イソチアゾロン−3−オン化合物等
を加える事ができる。 Furthermore, salicylic acid, phenol, butyl phenol-parabenzoate, sodium dehydroacetate, 4-isothiazolone-3-one compound, etc. can be added as preservatives.
以下に本発明の態様をしめす。 Aspects of the present invention are shown below.
態様1
更にPH調節剤、PH緩衝剤、湿潤剤、濡れ剤、防
腐剤、防錆剤等含有する特許請求の範囲記載の湿
し水。Embodiment 1 A dampening solution according to the claims, further containing a PH regulator, a PH buffer, a wetting agent, a wetting agent, a preservative, a rust preventive, and the like.
態様2
更に有機酸またはその塩を0.1〜50g/含有
する特許請求の範囲記載の湿し水。Embodiment 2 The dampening water according to the claims, further containing 0.1 to 50 g/of an organic acid or a salt thereof.
以下に本発明の実施例を示す。ただしこれによ
つて本発明か制約を受けるものではない。 Examples of the present invention are shown below. However, this does not limit the present invention.
実施例 1
黄血アンモニウム 4.0g
りん酸1ナトリウム 15.0g
フイチン酸 2.0g
水 1000.0g
本処方になる湿し水を用い、富士フイルム
ELPシステムにて製版、エチツング処理したマ
スターをDIC Fグロス墨インクで中性紙に印刷
した。刷り出しから1万枚までまつたく汚れるこ
となく鮮明に印刷できた。更にこの湿し水を補給
しながら印刷を続けたところ、5番で計5万枚の
印刷ができた。印刷中に汚れやローラーストリツ
プ、水負けといつたトラブルはまつたく発生しな
かつた。Example 1 Yellow Blood Ammonium 4.0g Monosodium Phosphate 15.0g Phytic Acid 2.0g Water 1000.0g Fujifilm
The master, which was plate-made and etched using the ELP system, was printed on neutral paper using DIC F gloss black ink. I was able to print 10,000 sheets clearly and without any smudges from the beginning of printing. When I continued printing while replenishing this dampening water, I was able to print a total of 50,000 sheets with No. 5. There were no problems such as stains, roller strips, or water damage during printing.
比較例 1
黄血ナトリウム 4.0g
りん酸1ナトリウム 15.0g
水 1000.0g
実施例1とまつたく同様の条件で印刷を行つた
ところ、3000枚で地汚れが発生した。そこで新し
いマスターに替え再度印刷をしたところ、刷り始
めから地汚れが発生した。Comparative Example 1 Sodium yellow blood 4.0g Monosodium phosphate 15.0g Water 1000.0g When printing was carried out under the same conditions as in Example 1, scumming occurred after 3000 sheets. So, when I changed to a new master and printed again, scumming occurred from the beginning of printing.
比較例 2
フイチン酸ナトリウム 12.0g
水 1000.0g
実施例1とまつたく同様の条件で印刷を行なつ
たところ、5000枚で耐刷不良が発生した。そこで
新しいマスターに替え再度印刷したが、やはり
5000枚で耐刷不良となつた。Comparative Example 2 Sodium phytate 12.0g Water 1000.0g When printing was carried out under the same conditions as in Example 1, printing durability failure occurred after 5000 sheets. So I replaced it with a new master and printed it again, but it still didn't work.
After 5,000 sheets, the print life became defective.
実施例 2
黄血ナトリウム 5.0g
りん酸1ナトリウム 15.0g
フイチン酸ナトリウム 1.0g
グルコン酸 15.0g
水 1000.0g
インキをDIC Fグロス群青に交換した以外実
施例1とまつたく同様の条件で印刷を行なつたと
ころ、3万枚以上まつたく地汚れも耐刷不良の発
生もなかつた。Example 2 Sodium yellow blood 5.0g Monosodium phosphate 15.0g Sodium phytate 1.0g Gluconic acid 15.0g Water 1000.0g Printing was carried out under exactly the same conditions as in Example 1 except that the ink was replaced with DIC F gloss ultramarine. As a result, over 30,000 copies were printed without any background stains or poor printing durability.
実施例 3
黄血カリウム 4.0g
りん酸1ナトリウム 10.0g
フイチン酸 0.5g
グリコール酸 6.0g
水 1000.0g
実施例1とまつたく同様の条件で印刷を行なつ
たところ、5万枚以上まつたく地汚れのの発生が
なかつた。Example 3 Yellow Blood Potassium 4.0g Monosodium Phosphate 10.0g Phytic Acid 0.5g Glycolic Acid 6.0g Water 1000.0g When printing was carried out under the same conditions as in Example 1, more than 50,000 sheets were smudged. There was no occurrence of
実施例 4
黄血カリウム 4.0g
りん酸1カリウム 20.0g
フイチン酸カリウム 2.0g
リンゴ酸 6.0g
EDTA−2Na 0.4g
グリセリン 8.0g
4−チアゾロン−3−オン化合物 0.02g
水 1000.0g
実施例1とまつたく同様の条件印刷を行なつた
ところ、5万枚以上まつたく地汚れの発生がなか
つた。また補給を続けながら一ケ月間連続使用し
たところ、地汚れ、ローラーストリツプ、水負
け、カビ、ヘドロ、沈澱、錆等の発生は皆無であ
り常に安定して鮮明な印刷物が得られた。Example 4 Yellow blood potassium 4.0g Monopotassium phosphate 20.0g Potassium phytate 2.0g Malic acid 6.0g EDTA-2Na 0.4g Glycerin 8.0g 4-thiazolone-3-one compound 0.02g Water 1000.0g Example 1 and eyelash When printing was carried out under the same conditions, over 50,000 copies were printed without any background smearing. After continuous use for one month with continued replenishment, there was no occurrence of scumming, roller strips, water damage, mold, sludge, sediment, rust, etc., and stable and clear prints were always obtained.
比較例 3
実施例3に示す処方において、フイチン酸を5
gに変更した湿し水を調製した。この湿し水を用
いて実施例1と全く同様の条件で印刷を行つたと
ころ、1000枚で着肉不良が発生した。Comparative Example 3 In the formulation shown in Example 3, 5 phytic acid
A dampening solution was prepared with a change in g. When printing was carried out using this dampening water under exactly the same conditions as in Example 1, defective inking occurred after 1000 sheets.
[発明の効果]
上記したように本発明の湿し水を用いるとき
は、地汚れ等の問題を発生せず多数枚の印刷物を
得ることができる。[Effects of the Invention] As described above, when using the dampening solution of the present invention, a large number of printed matter can be obtained without causing problems such as scumming.
Claims (1)
またはその塩を0.1〜2g/含有し、PHが3〜
7である印刷用湿し水。1 Contains at least 1 to 10 g of yellow blood salt, 0.1 to 2 g of phytic acid or its salt, and has a pH of 3 to 3.
7 dampening water for printing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14569885A JPS627596A (en) | 1985-07-04 | 1985-07-04 | Damping water for printing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14569885A JPS627596A (en) | 1985-07-04 | 1985-07-04 | Damping water for printing |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS627596A JPS627596A (en) | 1987-01-14 |
JPH043918B2 true JPH043918B2 (en) | 1992-01-24 |
Family
ID=15391038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14569885A Granted JPS627596A (en) | 1985-07-04 | 1985-07-04 | Damping water for printing |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS627596A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08216545A (en) * | 1995-02-17 | 1996-08-27 | Fuji Photo Film Co Ltd | Desensitizing treatment solution for direct writing type lithographic printing plate |
EP1730326A4 (en) | 2004-01-16 | 2008-05-28 | Battelle Memorial Institute | Methods and apparatus for producing ferrate (vi) |
DE602005027490D1 (en) | 2004-11-12 | 2011-05-26 | Battelle Memorial Inst Columbus | DECONTAMINATION AGENT |
WO2008112657A1 (en) | 2007-03-09 | 2008-09-18 | Battelle Memorial Institute | Ferrate(vi)-containing compositions and methods of using ferrate(vi) |
EP2268345A1 (en) | 2008-03-26 | 2011-01-05 | Battelle Memorial Institute | Apparatus and methods of providing diatomic oxygen (o2) using ferrate(vi)-containing compositions |
EP2342291A1 (en) | 2008-10-17 | 2011-07-13 | Battelle Memorial Institute | Corrosion resistant primer coating |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5410003A (en) * | 1977-06-23 | 1979-01-25 | Nippon Oils & Fats Co Ltd | Unsensitized resin making liquid for flat printing plate |
-
1985
- 1985-07-04 JP JP14569885A patent/JPS627596A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5410003A (en) * | 1977-06-23 | 1979-01-25 | Nippon Oils & Fats Co Ltd | Unsensitized resin making liquid for flat printing plate |
Also Published As
Publication number | Publication date |
---|---|
JPS627596A (en) | 1987-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4208212A (en) | Aqueous treating liquid for use in offset printing | |
US4764213A (en) | Lithographic fountain solution containing mixed colloids | |
JPH043918B2 (en) | ||
EP0654512B1 (en) | Printing ink composition | |
US3769043A (en) | Treating solution for planographic printing plates | |
US4834797A (en) | Fat-desensitizing composition for litho printing plates comprising phytic acid, polyethylene glycol and a glycol compound | |
US4734132A (en) | Lipophobicating solution for electrophotographic plates for offset printing contains phytic acid and at least two dicarboxylic acids | |
US5736256A (en) | Lithographic printing plate treated with organo-phosphonic acid chelating compounds and processes relating thereto | |
US3970455A (en) | Electrostatic lithographic printing process utilizing hydrophilizing composition | |
US4266481A (en) | Image-bearing lithographic plates with desensitizing coating | |
JPH0527558B2 (en) | ||
EP0144201B1 (en) | Plate cleaner for electrophotolithographic printing plate | |
US4200688A (en) | Method of treating image-bearing lithographic plates | |
JPH0352357B2 (en) | ||
US5336302A (en) | Non-alcohol fountain solutions | |
US3714891A (en) | Process of using multi-purpose lithographic solution | |
JPS62292492A (en) | Treating liquid for plranographic printing | |
US4013008A (en) | Methods and solutions for improvement of offset printing | |
JP2733534B2 (en) | Desensitizing solution for lithographic printing | |
JPS5814320B2 (en) | Desensitizing liquid for offset printing | |
EP0642931B1 (en) | Desensitizing solution for lithographic platemaking | |
JPS62218190A (en) | Treating liquid for planographic printing | |
US4053319A (en) | Hydrophilizing composition for lithographic printing plates | |
US3323451A (en) | Process and composition for producing planographic photoelectrostatic printing plates | |
KR100922312B1 (en) | New treating liquid composition for master print |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |